Altrius Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
47,926
+154
| +0.3% | +$17.1K | 1.24% | 36 |
|
|
2025
Q1 | $5.35M | Buy |
47,772
+370
| +0.8% | +$41.5K | 1.3% | 34 |
|
|
2024
Q4 | $4.38M | Sell |
47,402
-15,005
| -24% | -$1.39M | 1.18% | 46 |
|
|
2024
Q3 | $5.23M | Sell |
62,407
-1,805
| -3% | -$151K | 1.31% | 32 |
|
|
2024
Q2 | $4.41M | Buy |
64,212
+11,232
| +21% | +$771K | 1.16% | 48 |
|
|
2024
Q1 | $3.88M | Buy |
52,980
+6,060
| +13% | +$444K | 0.98% | 64 |
|
|
2023
Q4 | $3.8M | Buy |
46,920
+58
| +0.1% | +$4.7K | 1.06% | 49 |
|
|
2023
Q3 | $3.51M | Buy |
46,862
+728
| +2% | +$54.6K | 1.04% | 44 |
|
|
2023
Q2 | $3.56M | Buy |
46,134
+200
| +0.4% | +$15.4K | 1.05% | 42 |
|
|
2023
Q1 | $3.81M | Buy |
45,934
+323
| +0.7% | +$26.8K | 1.17% | 30 |
|
|
2022
Q4 | $3.92M | Sell |
45,611
-1,457
| -3% | -$125K | 1.23% | 28 |
|
|
2022
Q3 | $2.9M | Sell |
47,068
-18,325
| -28% | -$1.13M | 1.11% | 43 |
|
|
2022
Q2 | $4.04M | Buy |
+65,393
| New | +$4.04M | 1.31% | 38 |
|